Argent BioPharma Limited (ASX:RGT), an innovative multidisciplinary drug discovery company within the biopharmaceutical sector, has announced the publication of its Company Presentation for June 2024:
Argent BioPharma is a Clinical-Stage, Revenue Generating Biopharmaceutical Company committed to providing accessible medical treatments for unmet medical needs, to bridge the gap where medical solutions currently fall short.
You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular stock, share, security, portfolio of securities, transaction, investment strategy, or other matter. We openly disclose that we and our contributors may have interests in investments and/or providers of services referred to within the website and that we receive remuneration from certain of the companies referred to on this website.
